| Literature DB >> 24626222 |
Zhongbao Gao1, Wei Wang1, Zhenfu Wang1, Xingli Zhao1, Yanchang Shang1, Yaner Guo1, Mei Gong1, Lijuan Yang1, Xiaobing Shi1, Xian Xu2, Ningyu An2, Weiping Wu1.
Abstract
Cerebral microbleeds (CMBs) and white matter hyperintensities (WMH) are the most common manifestations of small vessel disease, and often co-occur in patients with cerebral vascular disease. Hypertension is widely accepted as a risk factor for both CMBs and WMH. However, the effect of hypertension on the association between CMBs and WMH remains unclear. We hypothesized that the relationship between CMBs and WMH is determined by hypertension. One hundred forty-eight patients with acute cerebrovascular disease who were admitted to PLA general hospital in Beijing, China from February 2010 to May 2011 were recruited in this study. CMBs on T2*-weighted angiography (SWAN) were assessed using the Brain Observer Microbleed Rating Scale criteria. The severity of the WMH was separately assessed as either peri-ventricular hyperintensities (PVH) or deep white matter hyperintensities (DWMH). The association among CMBs and the severity of WMH, and hypertension were determined. CMBs were found in 65 (43.9%) patients. The frequency of CMBs was related to the severity of DWMH and PVH. CMBs were more frequently observed in patients with hypertension compared to patients without hypertension (51.3% vs. 20.0%, p = 0.001). Hypertension was an independent risk factor for CMBs (odds ratio 5.239, p = 0.001) and DWMH (odds ratio 2.373, p = 0.040). Furthermore, the relationship between the presence of CMBs and the severity of DWMH was only found in patients with hypertension (r = 0.298, p<0.01). However, CMBs were associated with PVH independently of hypertension. This study demonstrated that hypertension determined the association between CMBs and DWMH.Entities:
Mesh:
Year: 2014 PMID: 24626222 PMCID: PMC3953489 DOI: 10.1371/journal.pone.0091637
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Figure 1The location of cerebral microbleeds (CMBs) on 3D-enhanced T2*-weighted gradient echo sequence of MRI (arrows).
(A) CMBs in frontal lobe. (B) CMBs in thalamus.
Figure 2White matter hyperintensities on T2-fluid-attenuated inversion recovery sequence (T2-FLAIR).
Deep white matter hyperintensities (DWMH) and peri-ventricular hyperintensities (PVH) was indicated by arrow and arrow head, respectively.
Clinical Characteristics.
| ICH (n = 8) | IS (n = 63) | TIA (n = 20) | Lacunar Stroke (n = 57) | |
| Age Mean (SD) | 81.3(13.0) | 84.4(6.9) | 83.1(6.8) | 79.6(8.7) |
| Male gender | 8(100.0) | 60(95.2) | 19(95.0) | 56(98.2) |
| Current smoker | 6(75.0) | 39(61.9) | 11(55.0) | 32(56.1) |
| Current drinker | 1(12.5) | 20(31.7) | 5(25.0) | 19(33.3) |
| History of diabetes mellitus | 2(25.0) | 26(41.3) | 6(30.0) | 23(40.4) |
| History of hypertension | 6(75.0) | 55(87.3) | 13(65.0) | 39(68.4) |
| History of hyperlipidemia | 1(12.5) | 10(15.9) | 5(25.0) | 15(26.3) |
| Usage of anti-platelet drugs | 6(75.0) | 53(84.1) | 17(85.0) | 43(75.4) |
| Presence of CMBs | 6(75.0) | 35(55.6) | 3(15.0) | 21(36.8) |
| Presence of PVH | 4(50.0) | 49(77.8) | 14(70.0) | 28(49.1) |
| Presence of DWMH | 4(50.0) | 53(84.1) | 12(60.0) | 28(49.1) |
TIA = Transient ischemia stroke; ICH = Intracranial hemorrhage; IS = Ischemic stroke;
SD = Standard deviation.
Risk Factors for CMBs, PVH, DWMH and LI (OR, 95% CI).
| CMBs | PVH | DWMH | LI | |
| OR(95%CI) | OR(95%CI) | OR(95%CI) | OR(95%CI) | |
| Age per 10 years | 1.828(1.164–2.871) | 2.994(1.797–4.990) | 1.404(0.916–2.152) | 1.077(0.673–1.725) |
| Male gender | 2.380(0.323–17.546) | 9.785(1.130–84.744) | 1.513(0.202–11.309) | 0.691(0.068–6.994) |
| Current smoker | 0.536(0.237–1.211) | 0.690(0.289–1.648) | 0.840(0.382–1.848) | 0.828(0.354–1.938) |
| Current drinker | 1.393(0.598–3.246) | 0.889(0.369–2.143) | 0.964(0.427–2.173) | 1.661(0.657–4.202) |
| History of diabetes mellitus | 1.327(0.633–2.781) | 0.982(0.446–2.162) | 0.743(0.362–1.522) | 1.725(0.754–3.947) |
| History of hypertension | 5.239(1.975–13.898) | 2.360(0.965–5.775) | 2.373(1.038–5.424) | 1.897(0.787–4.574) |
| History of hyperlipidemia | 0.564(0.227–1.400) | 1.666(0.618–4.490) | 1.128(0.477–2.662) | 0.884(0.341–2.296) |
| Usage of antiplatelet drugs | 0.813(0.316–2.092) | 1.606(0.623–4.135) | 1.404(0.916–2.152) | 0.602(0.212–1.707) |
CMBs = Cerebral microbleeds; PVH = Peri-ventricular hyperintensities; DWMH = Deep white matter hyperintensities; LI = Lacunar infarcts.
Figure 3The relationship between cerebral microbleeds (CMBs) and white matter hyperintensities.
The proportion of patients with CMBs increased with the severity of deep white matter hyperintensities (DWMH) (p<0.001, χ2 test) and peri-ventricular hyperintensities (PVH) (p<0.001, χ2 test). Each bar represents the number of patients.
Correlations amongst CMBs, WML, LI and risk factors (r).
| Age | Hypertension | CMBs | PVH | DWMH | LI | |
| Age | 1 | 0.003 | 0.166 | 0.377 | 0.228 | −0.006 |
| Hypertension | 1 | 0.268 | 0.143 | 0.209 | 0.110 | |
| CMBs | 1 | 0.347 | 0.314 | 0.146 | ||
| PVH | 1 | 0.759 | 0.060 | |||
| DWMH | 1 | 0.075 | ||||
| LI | 1 |
CMBs = Cerebral microbleeds; PVH = Peri-ventricular hyperintensities;
DWMH = Deep white matter hyperintensities; LI = Lacunar infarcts;
*p<0.05,
**p<0.01.
Correlation between the presence of CMBs and PVH, DWMH stratified by hypertension(r).
| With hypertension | Without hypertension | |||||||||
| Age | CMBs | PVH | DWMH | LI | Age | CMBs | PVH | DWMH | LI | |
| Age | 1 | 0.196 | 0.429 | 0.253 | 0.092 | 1 | 0.059 | 0.183 | 0.132 | −0.331 |
| CMBs | 1 | 0.314 | 0.298 | 0.183 | 1 | 0.366 | 0.145 | −0.090 | ||
| PVH | 1 | 0.778 | 0.076 | 1 | 0.650 | −0.050 | ||||
| DWMH | 1 | 0.065 | 1 | 0.015 | ||||||
| LI | 1 | 1 | ||||||||
CMBs = Cerebral microbleeds; PVH = Peri-ventricular hyperintensities;
DWMH = Deep white matter hyperintensities; LI = Lacunar infarcts;
*p<0.05,
**p<0.01.
Correlation between the distribution of CMBs and presence of PVH, DWMH (%, n).
| Type of CMBs | ||||||
| NO CMBs (n = 83) | Lobar CMBs (n = 17) | Deep CMBs (n = 25) | Mixed CMBs (n = 23) | χ2 |
| |
| PVH(+) | 49.4%(41) | 76.5%(13) | 84.0%(21) | 87.0%(20) | 18.471 | <0.001 |
| DWMH(+) | 48.2%(40) | 58.8%(10) | 72.0%(15) | 87.0%(20) | 13.219 | 0.004 |
CMBs = Cerebral microbleeds; PVH = Peri-ventricular hyperintensities;
DWMH = Deep white matter hyperintensities.
Correlation between the severity of CMBs and presence of PVH, DWMH (%, n).
| Severity of CMBs | ||||||
| Grade 0 (n = 83) | Grade 1 (n = 22) | Grade 2 (n = 30) | Grade3 (n = 13) | χ2 |
| |
| PVH(+) | 49.4%(41) | 77.3%(17) | 80.0%(24) | 100.0%(13) | 20.054 | <0.001 |
| DWMH(+) | 48.2%(40) | 63.6%(14) | 73.3%(22) | 92.3%(112) | 12.745 | 0.005 |
CMBs = Cerebral microbleeds; PVH = Peri-ventricular hyperintensity;
DWMH = Deep white matter hyperintensity.